Abstract
Galbanic acid (GBA), a major compound of Ferula assafoetida, was known to have cytotoxic, anti-angiogenic and apoptotic effects in prostate cancer and murine Lewis lung cancer cells; the underling apoptotic mechanism of GBA still remains unclear so far. Thus, in the present study, the apoptotic mechanism of GBA was investigated mainly in H460 non-small cell lung carcinoma (NSCLC) cells because H460 cells were most susceptible to GBA than A549, PC-9 and HCC827 NSCLC cells. Galbanic acid showed cytotoxicity in wild EGFR type H460 and A549 cells better than other mutant type PC-9 and HCC827 NSCLC cells. Also, GBA significantly increased the number of Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive cells and sub G1 population in H460 cells. Western blotting revealed that GBA cleaved poly (ADP-ribose) polymerase (PARP), activated Bax and caspase 9, attenuated the expression of Bcl-2, Bcl-x(L), and Myeloid cell leukemia 1 (Mcl-1) in H460 cells. However, interestingly, overexpression of Mcl-1 blocked the ability of GBA to exert cytotoxicity, activate caspase9 and Bax, cleave PARP, and increase sub G1 accumulation in H460 cells. Overall, these findings suggest that GBA induces apoptosis in H460 cells via c...Continue Reading
References
Mar 9, 2005·Cancer Biology & Therapy·Lanxi SongEric B Haura
Jan 7, 2006·Cancer Research·Cheng JiangJunxuan Lu
Sep 11, 2007·Biological & Pharmaceutical Bulletin·Ahmad Reza ShahverdiMehrdad Iranshahi
May 7, 2009·Diagnostic Cytopathology·Lilach Kleinberg, Ben Davidson
Feb 2, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayE Steliarova-Foucher
Jun 15, 2010·FEBS Letters·Luke W ThomasSteven W Edwards
Oct 26, 2010·Biochimica Et Biophysica Acta·Liam PorttMichael T Greenwood
Nov 11, 2010·Pharmaceutical Research·Kwan-Hyun KimSung-Hoon Kim
Feb 18, 2011·International Journal of Cancer. Journal International Du Cancer·Yong ZhangJunxuan Lü
Apr 13, 2011·Planta medica·Mohammad Yahya Hanafi-BojdJavad Behravan
Jul 1, 2011·The New England Journal of Medicine·UNKNOWN National Lung Screening Trial Research TeamJoRean D Sicks
Nov 30, 2011·TheScientificWorldJournal·Eric Milot, János G Filep
Mar 3, 2012·World Neurosurgery·Judith A Murovic, Steven D Chang
Apr 24, 2012·Clinical Breast Cancer·Roberto OchoaOrlando Silva
Jul 20, 2012·The American Journal of Chinese Medicine·Chong-Zhi WangChun-Su Yuan
Oct 4, 2012·Cell Proliferation·L OuyangJ-K Bao
Feb 19, 2013·PloS One·Sandeep SinghSrikumar P Chellappan
May 25, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Seied Mojtaba ValiahdiAmirhossein Sahebkar
Jun 27, 2013·Frontiers in Oncology·Sacha I Rothschild
Jul 26, 2013·Molecular Cancer Therapeutics·Sun Mi KimByoung Chul Cho
Aug 27, 2013·Leukemia Research Reports·Prithviraj Bose, Steven Grant
Oct 10, 2013·Journal of Palliative Medicine·Deniz ArslanEmre Akar
Oct 15, 2013·PloS One·Harish Chandra PalFarrukh Afaq
Citations
Aug 1, 2015·The Analyst·Wei TangChun-Yang Zhang
Jun 8, 2018·Current Medicinal Chemistry·Tijana StankovićMilica Pešić
Mar 20, 2020·Molecular Carcinogenesis·Qicheng ZhangKe Xu
Feb 12, 2020·Biomedical Reports·Nattpawit KaewnoonualWisuit Pradidarcheep
Mar 16, 2017·Frontiers in Pharmacology·Paola De CiccoAngela Ianaro
Nov 2, 2019·Journal of Cellular Physiology·Maryam AfsharzadehMohammad Ramezani
Jan 20, 2016·Oncology Reports·Quan-Guang RenQiu-Shuang Wang
Nov 22, 2019·Anti-cancer Agents in Medicinal Chemistry·Rumana AhmadArvind K Srivastava
Nov 22, 2020·Bioorganic & Medicinal Chemistry·Yang-Liu XiaGuang-Bo Ge